Linda Nelsen

Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial

Geoffrey Chupp, Eric Bradford, Frank C. Albers et al. · The Lancet Respiratory Medicine · 2017 · 590 citations

Medicine, Pharmacology, Pharmacotherapy +14

Adherence to Prescribed Treatment for Asthma: Evidence from Pharmacy Benefits Data

Craig Jones, Nancy C. Santanello, Steve J. Boccuzzi et al. · Journal of Asthma · 2003 · 132 citations

Pharmacy, Pharmacotherapy, Pharmacy Practice +17

Measuring respiratory symptoms of COPD: performance of the EXACT- Respiratory Symptoms Tool (E-RS) in three clinical trials

Nancy Kline Leidy, Lindsey Murray, Brigitta U. Monz et al. · Respiratory Research · 2014 · 125 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Biologic treatment eligibility for real-world patients with severe asthma: The IDEAL study

Frank C. Albers, Hana Müllerová, Necdet B. Gunsoy et al. · Journal of Asthma · 2017 · 109 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +14

Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary

Nancy Kline Leidy, Christopher Sexton, Paul Jones et al. · Thorax · 2014 · 75 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16